tiprankstipranks
Trending News
More News >
ADMA Biologics (ADMA)
NASDAQ:ADMA
US Market

ADMA Biologics (ADMA) Revenue

Compare
2,977 Followers

ADMA Biologics Revenue

ADMA Biologics had a revenue of 139.16M in the quarter ending Dec 31, 2025, with 3.68%. This bring the company's revenue in the last twelve months to 510.17M, Decreased 4.42%. In the fiscal year ending Dec 31, 2025, ADMA Biologics had annual revenue of 510.17M with 19.63% growth.
Revenue (ttm)
510.17M
Revenue Growth
27.62%
P/S Ratio
7.65
Revenue/Employee
$744,778
Employees
685
Market Cap
$3.90B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
510.17M83.72M+19.63%
Dec 31, 2024
426.45M168.24M+65.15%
Dec 31, 2023
258.21M104.14M+67.59%
Dec 31, 2022
154.08M73.14M+90.36%
Dec 31, 2021
80.94M38.72M+91.72%
Dec 31, 2020
42.22M12.87M+43.85%
Dec 31, 2019
29.35M12.36M+72.79%
Dec 31, 2018
16.99M-5.78M-25.37%
Dec 31, 2017
22.76M